Estroven Maximum Strength + Energy

Natural health product licensed in Canada

Other names: Estroven Stress Relief + Energy Boost
Licence holder: i-Health Inc.
NPN or DIN-HM: 80066222
Status: Active licence
Licence date: 5 January 2016
Revision date: 6 June 2025
Form: Comprimé
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
1,3,7-triméthylxanthine Source : Camellia sinensis - feuille	51 mg	Not calculated
1,3,7-triméthylxanthine Source : Ilex paraguariensis - feuille	51 mg	Not calculated
Actaea racemosa Source : Actaea racemosa - racine Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 480 mg	80 mg	Not calculated
Magnolia officinalis Source : Rhizome bark Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 300 mg	15 mg	Not calculated
Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 171:1 Dry plant equivalent : 26,505 mg Potency : 31 mg ÉAI Genistein	155 mg	Not calculated
Glycine max Source : Glycine max - Graine Potency : 62 mg ÉAI Isoflavones	Not specified	Not calculated

Non-medicinal ingredients

Acide stéarique, Hydroxypropyl méthylcellulose, Cellulose microcristalline, Dioxyde de titane, Phosphate dicalcique, Silice, Riboflavine, Croscarmellose de sodium, Poly(éthylène glycol), Stéarate de magnésium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Sexe féminin	Not specified	1 Comprimé	1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Soy isoflavones may reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats). Black Cohosh helps relieve symptoms associated with menopause. Caffeine helps temporarily relieve fatigue and promote alertness. May help to reduce irritability associated with menopause. Black cohosh is used in herbal medicine to help ease nervous tension (calmative).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.